Abstract
The pro-inflammatory cytokine interleukin-6 (IL-6) together with its soluble receptor (sIL-6R) induces and maintains thermal hyperalgesia. It facilitates the heat-induced release of calcitonin gene-related peptide from rat cutaneous nociceptors in vivo and in vitro. Here we report that exposure of nociceptive neurons to the IL-6-sIL-6R complex or the gp130-stimulating designer IL-6-sIL-6R fusion protein Hyper-IL-6 (HIL-6) resulted in a potentiation of heat-activated inward currents (I(heat)) and a shift of activation thresholds towards lower temperatures without affecting intracellular calcium levels. The Janus tyrosine kinase inhibitor AG490, the selective protein kinase C (PKC) inhibitor, bisindolylmaleimide 1 (BIM1), as well as rottlerin, a selective blocker of the PKCdelta isoform, but not the cyclooxygenase inhibitor indomethacin, effectively reduced the effect. Reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization revealed expression of mRNA for the signal-transducing beta subunit of the receptor gp130 in neuronal somata, rather than satellite cells in rat dorsal root ganglia. Together, the results suggest that IL-6-sIL-6R acts directly on sensory neurons. It increases their susceptibility to noxious heat via the gp130/Jak/PKCdelta signalling pathway.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetophenones / pharmacology
-
Animals
-
Antigens, CD / genetics
-
Antigens, CD / metabolism
-
Benzopyrans / pharmacology
-
Calcium / metabolism
-
Cells, Cultured
-
Cyclooxygenase Inhibitors / pharmacology
-
Cytokine Receptor gp130
-
Female
-
Ganglia, Spinal / drug effects
-
Ganglia, Spinal / physiology*
-
Hot Temperature / adverse effects*
-
In Situ Hybridization
-
Indoles / pharmacology
-
Indomethacin / pharmacology
-
Interleukin-6 / genetics
-
Interleukin-6 / pharmacology*
-
Janus Kinase 1
-
Maleimides / pharmacology
-
Membrane Glycoproteins / genetics
-
Membrane Glycoproteins / metabolism
-
Neurons, Afferent / drug effects
-
Neurons, Afferent / physiology*
-
Protein Kinase C / antagonists & inhibitors
-
Protein Kinase C-delta
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
RNA, Messenger / analysis
-
Rats
-
Rats, Wistar
-
Receptors, Interleukin-6 / genetics
-
Receptors, Interleukin-6 / metabolism*
-
Recombinant Fusion Proteins / pharmacology
-
Reverse Transcriptase Polymerase Chain Reaction
-
Sensory Thresholds / drug effects
-
Signal Transduction / drug effects
-
Tyrphostins / pharmacology
Substances
-
Acetophenones
-
Antigens, CD
-
Benzopyrans
-
Cyclooxygenase Inhibitors
-
Il6st protein, rat
-
Indoles
-
Interleukin-6
-
Maleimides
-
Membrane Glycoproteins
-
RNA, Messenger
-
Receptors, Interleukin-6
-
Recombinant Fusion Proteins
-
Tyrphostins
-
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
-
Cytokine Receptor gp130
-
rottlerin
-
Prkcd protein, rat
-
Protein-Tyrosine Kinases
-
Jak1 protein, rat
-
Janus Kinase 1
-
Protein Kinase C
-
Protein Kinase C-delta
-
bisindolylmaleimide
-
Calcium
-
Indomethacin